Endoscopic Resection Multicenter Registry
Endoscopic Resection: A Retrospective and Prospective Multicenter Registry
1 other identifier
observational
200
1 country
1
Brief Summary
This is a retrospective and prospective multicenter registry to collect long-term data (1 year) on patients who have or will undergo Endoscopic resection such as EMR, ESD, EFTR, STER, etc. within the gastrointestinal tract for endoscopic treatment of early gastrointestinal neoplasms involving the resection of the superficial layers, mucosa and submucosa, of the tract wall. Subjects will be consented for medical chart review. The purpose of this retrospective and prospective registry is to assess long term data on efficacy, safety and clinical outcome of Endoscopic Resection within the gastrointestinal tract (1 year). The registry will evaluate efficacy, technical feasibility, clinical outcome, safety profile and overall clinical management through medical chart review. The procedures the investigators are evaluating are all clinically indicated and will not be prescribed to someone to participate in this registry study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 16, 2017
CompletedFirst Posted
Study publicly available on registry
February 27, 2017
CompletedStudy Start
First participant enrolled
March 15, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2020
CompletedApril 25, 2017
April 1, 2017
3 years
February 16, 2017
April 21, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of participants with reduction in clinical symptoms
To assess resolution of symptoms of all Endoscopic resection procedures at 6 months
6 months from procedure
Secondary Outcomes (1)
Number of participants with treatment-related adverse events as assessed by CTCAE v4.0
30 days post procedure
Other Outcomes (1)
Number of participants with successful completion of treatment
30 days post procedure
Study Arms (1)
Endoscopic Resection
Patients undergoing Endoscopic Resection
Interventions
Any Endoscopic resection for Gastrointestinal disorders including neoplasms.
Eligibility Criteria
Subjects undergoing Endoscopic resection procedures as part of their clinically indicated care
You may qualify if:
- Any patient who is considering undergoing endoscopic resection within 6 months, or has undergone clinically indicated endoscopic resection within the past 6 months
- Above or equal to 18 years of age.
You may not qualify if:
- Any patient who has not undergone or will undergo endoscopic resection
- Below 18 years of age.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Weill Cornell Medical College
New York, New York, 10065, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michel Kahaleh, MD
Weill Medical College of Cornell University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief of Endoscopy
Study Record Dates
First Submitted
February 16, 2017
First Posted
February 27, 2017
Study Start
March 15, 2017
Primary Completion
March 1, 2020
Study Completion
April 1, 2020
Last Updated
April 25, 2017
Record last verified: 2017-04
Data Sharing
- IPD Sharing
- Will not share
No IPD Sharing